United States (US) Artificial Heart Market (2025-2031) | Industry, Competitive Landscape, Forecast, Analysis, Outlook, Trends, Size & Revenue, Companies, Share, Value, Segmentation, Growth

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Artificial Heart Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Artificial Heart Market - Industry Life Cycle

3.4 United States (US) Artificial Heart Market - Porter's Five Forces

3.5 United States (US) Artificial Heart Market Revenues & Volume Share, By Type, 2021 & 2031F

3.6 United States (US) Artificial Heart Market Revenues & Volume Share, By End-User, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Technological advancements in artificial heart technology leading to improved efficacy and safety.

4.2.2 Increasing prevalence of cardiovascular diseases and heart failure cases driving the demand for artificial heart devices.

4.2.3 Rising investments in healthcare infrastructure and research development activities in the field of cardiology.

4.3 Market Restraints

4.3.1 High cost associated with artificial heart devices limiting access to a broader patient population.

4.3.2 Regulatory challenges and stringent approval processes for artificial heart devices affecting market growth.

4.3.3 Limited availability of skilled healthcare professionals proficient in artificial heart implantation and management.

6.1 United States (US) Artificial Heart Market, By Type

6.1.1 Overview and Analysis

6.1.2 United States (US) Artificial Heart Market Revenues & Volume, By Type, 2021- 2031F

6.1.3 United States (US) Artificial Heart Market Revenues & Volume, By Bioanalytical Testing Services, 2021- 2031F

6.1.4 United States (US) Artificial Heart Market Revenues & Volume, By Physical Characterization Services, 2021- 2031F

6.1.5 United States (US) Artificial Heart Market Revenues & Volume, By Method Development, 2021- 2031F

6.1.6 United States (US) Artificial Heart Market Revenues & Volume, By Validation Services, 2021- 2031F

6.1.7 United States (US) Artificial Heart Market Revenues & Volume, By Raw Material Testing Services, 2021- 2031F

6.1.8 United States (US) Artificial Heart Market Revenues & Volume, By Batch-Release Testing Services, 2021- 2031F

6.1.9 United States (US) Artificial Heart Market Revenues & Volume, By Microbial Testing Services, 2021- 2031F

6.1.10 United States (US) Artificial Heart Market Revenues & Volume, By Microbial Testing Services, 2021- 2031F

6.2 United States (US) Artificial Heart Market, By End-User

6.2.1 Overview and Analysis

6.2.2 United States (US) Artificial Heart Market Revenues & Volume, By Pharmaceutical and Biopharmaceutical Companies, 2021- 2031F

6.2.3 United States (US) Artificial Heart Market Revenues & Volume, By Medical Device Companies, 2021- 2031F

6.2.4 United States (US) Artificial Heart Market Revenues & Volume, By Contract Research Organizations, 2021- 2031F

7.1 United States (US) Artificial Heart Market Export to Major Countries

7.2 United States (US) Artificial Heart Market Imports from Major Countries

8.1 Survival rate post-implantation of artificial hearts.

8.2 Average length of hospital stay for patients receiving artificial heart implants.

8.3 Number of clinical trials and research studies conducted on artificial heart technology.

8.4 Adoption rate of artificial heart devices in different healthcare facilities.

8.5 Patient satisfaction and quality of life improvements after receiving artificial heart implants.

9.1 United States (US) Artificial Heart Market Opportunity Assessment, By Type, 2021 & 2031F

9.2 United States (US) Artificial Heart Market Opportunity Assessment, By End-User, 2021 & 2031F

10.1 United States (US) Artificial Heart Market Revenue Share, By Companies, 2024

10.2 United States (US) Artificial Heart Market Competitive Benchmarking, By Operating and Technical Parameters